Nitric oxide-releasing hyaluronan microgels for enhanced post-shaving skin recovery
Innovative microgels combining hyaluronan and nitric oxide for post-shaving care, offering hydration, antimicrobial protection, and anti-inflammatory benefits to accelerate skin recovery and reduce scarring.
Overview
Nitric oxide-releasing hyaluronan microgels are designed to transform post-shaving skin care by integrating multiple skincare benefits into a single, advanced formulation. These microgels leverage the hydrating and skin barrier-supporting properties of hyaluronan (HA) along with the antimicrobial and anti-inflammatory capabilities of nitric oxide (NO). The result is a multifunctional solution that aids in rapid wound healing, reduces irritation, prevents infections, and minimizes scars and dark spots. This innovative technology addresses the growing demand for fast-acting, multifunctional skincare products that outperform traditional post-shaving solutions.
Technical specifications
- Hyaluronan (HA) Properties: HA is known for its ability to hydrate, strengthen the skin barrier, soothe irritation, and support wound healing and scar reduction.
- Nitric Oxide (NO) Benefits: NO enhances healing by promoting blood flow, collagen synthesis, and tissue regeneration. It also offers antimicrobial action to prevent infections.
- Synergistic Functionality: The combination of HA and NO provides comprehensive post-shaving care, addressing hydration, inflammation, microbial control, and scar prevention.
Technology readiness level
The nitric oxide-releasing hyaluronan microgels are at Technology Readiness Level 4, indicating that the technology has been validated in a laboratory setting. Ongoing development includes in vitro and in vivo testing phases, with aims to optimize formulations and prepare for commercialization.
About University of Galway
University of Galway is a comprehensive public research university on Ireland’s Atlantic coast, combining academic breadth with a strongly applied, partnership‑driven culture. Its integration with University Hospital Galway and the Saolta University Health Care Group gives companies access to clinicians, patients and trial infrastructure for timely translation. For industry, an Innovation Office and an Institute for Clinical Trials offer clear entry points for collaboration, IP and contracting, while proximity to Galway’s medtech hub supports rapid prototyping and validation. Research is supported by competitive national and European programmes, including Science Foundation Ireland and EU funding. A dedicated technology transfer office streamlines IP, licensing and startup formation.
Inquire about this partnering listing
Industry applications
delivered to your inbox.